rs386833851
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_004260.4(RECQL4):c.2476C>T(p.Arg826*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000363 in 1,541,040 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_004260.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RECQL4 | NM_004260.4 | c.2476C>T | p.Arg826* | stop_gained | 15/21 | ENST00000617875.6 | NP_004251.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RECQL4 | ENST00000617875.6 | c.2476C>T | p.Arg826* | stop_gained | 15/21 | 1 | NM_004260.4 | ENSP00000482313.2 | ||
RECQL4 | ENST00000621189.4 | c.1405C>T | p.Arg469* | stop_gained | 14/20 | 1 | ENSP00000483145.1 | |||
RECQL4 | ENST00000534626.6 | c.646C>T | p.Arg216* | stop_gained | 6/8 | 5 | ENSP00000477457.1 | |||
ENSG00000265393 | ENST00000580385.1 | n.271+289G>A | intron_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000470 AC: 7AN: 148890Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000540 AC: 11AN: 203756Hom.: 0 AF XY: 0.0000544 AC XY: 6AN XY: 110258
GnomAD4 exome AF: 0.0000352 AC: 49AN: 1392150Hom.: 0 Cov.: 66 AF XY: 0.0000292 AC XY: 20AN XY: 686022
GnomAD4 genome AF: 0.0000470 AC: 7AN: 148890Hom.: 0 Cov.: 34 AF XY: 0.0000414 AC XY: 3AN XY: 72462
ClinVar
Submissions by phenotype
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jan 01, 2024 | RECQL4: PVS1, PM3:Strong, PM2 - |
Pathogenic, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Feb 03, 2017 | - - |
Rapadilino syndrome Pathogenic:1
Likely pathogenic, no assertion criteria provided | literature only | Juha Muilu Group; Institute for Molecular Medicine Finland (FIMM) | - | - - |
Baller-Gerold syndrome;C1849453:Rapadilino syndrome;C5203410:Rothmund-Thomson syndrome type 2 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Nov 29, 2021 | - - |
Hereditary cancer-predisposing syndrome Pathogenic:1
Pathogenic, criteria provided, single submitter | curation | Sema4, Sema4 | Sep 29, 2021 | - - |
Baller-Gerold syndrome Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 21, 2023 | This sequence change creates a premature translational stop signal (p.Arg826*) in the RECQL4 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in RECQL4 are known to be pathogenic (PMID: 12734318, 12952869). This variant is present in population databases (rs386833851, gnomAD 0.03%). This premature translational stop signal has been observed in individual(s) with Rothmund–Thomson syndrome (PMID: 12734318, 18716613). This variant is also known as g.3685G>A. ClinVar contains an entry for this variant (Variation ID: 56406). For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at